James Brorson to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications James Brorson has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Connection Strength
1.264
-
Statin initiation and early stroke recurrence in the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke Trial (POINT) trial population. J Stroke Cerebrovasc Dis. 2025 Jul; 34(7):108349.
Score: 0.698
-
Predictors of very early stroke recurrence in the POINT trial population. BMC Neurol. 2022 May 14; 22(1):177.
Score: 0.567